Celltrion, Inc. today announced that six abstracts will be presented at the 2025 Digestive Disease Week® (DDW) Annual Meeting, taking place May 3-6 in San Diego, California. The oral and poster ...

Six abstracts accepted for presentation includes post hoc analyses and real-world evidence for ZYMFENTRA ® (infliximab-dyyb) Findings reinforce clinical decision-making in long-term management of ...

INCHEON, South Korea, April 28, 2025 /PRNewswire/ -- Celltrion, Inc. today announced that six abstracts will be presented at the 2025 Digestive Disease Week ® (DDW) Annual Meeting, taking place May ...